Vault-13

AN2 THEREAPEUTICS INC

COM · CUSIP 373261056

1 institutional holders +0 vs Q1 2026
367,435367.4k shares reported held*
$1.8mreported value*
0 new 0 added 1 reduced 0 sold out net sold ≈ $21.0k (-4.3k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.84.

Trends to Q2 2026

Institutional holders

Managers reporting a position, each quarter

001Q2 25: 1Q3 25: 1Q4 25: 1Q1 26: 1Q2 26: 11Q2 25Q3 25Q4 25Q1 26Q2 26
Numbers
QuarterHolders
Q2 20251
Q3 20251
Q4 20251
Q1 20261
Q2 20261

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q3 25: 0 bought or addedQ3 25: 1 cut or sold outQ3 25Q4 25: 0 bought or addedQ4 25: 1 cut or sold outQ4 25Q1 26: 0 bought or addedQ1 26: 1 cut or sold outQ1 26Q2 26: 0 bought or addedQ2 26: 1 cut or sold outQ2 26
Numbers
QuarterBought or addedCut or sold out
Q3 202501
Q4 202501
Q1 202601
Q2 202601

Biggest buyers

None

Biggest sellers

Aldebaran Capital, LLC Reduced -4,335-4.3k

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Aldebaran Capital, LLC 1.34% of their portfolio CARMEL, IN 367,435367.4k $1.8m $1.8m 1.34% Reduced -4.3k -4,335